Colin George Stott - Net Worth and Insider Trading

Colin George Stott Net Worth

The estimated net worth of Colin George Stott is at least $264,000 dollars as of 2024-09-23. Colin George Stott is the Director of Cardiol Therapeutics Inc and owns about 82,500 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $264,000. Details can be seen in Colin George Stott's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Colin George Stott has not made any transactions after 2021-02-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Colin George Stott

To

Colin George Stott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Colin George Stott owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .

Click here to see the complete history of Colin George Stott’s form 4 insider trades.

Insider Ownership Summary of Colin George Stott

Ticker Comapny Transaction Date Type of Owner
TSX:CRDL Cardiol Therapeutics Inc 2021-02-25 Director

Colin George Stott Latest Holdings Summary

Colin George Stott currently owns a total of 1 stock. Colin George Stott owns 82,500 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of February 25, 2021, with a value of $264,000.

Latest Holdings of Colin George Stott

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:CRDL Cardiol Therapeutics Inc 2021-02-25 82,500 3.20 264,000

Holding Weightings of Colin George Stott


Colin George Stott Form 4 Trading Tracker

According to the SEC Form 4 filings, Colin George Stott has made a total of 1 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 22,500 shares on February 25, 2021, which cost Colin George Stott around $99,450.

Insider Trading History of Colin George Stott

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Colin George Stott Trading Performance

GuruFocus tracks the stock performance after each of Colin George Stott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Colin George Stott is -26.82%. GuruFocus also compares Colin George Stott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Colin George Stott within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Colin George Stott's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Colin George Stott

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.32 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.23 LIMIT LIMIT LIMIT LIMIT LIMIT

Colin George Stott Ownership Network

Ownership Network List of Colin George Stott

No Data

Ownership Network Relation of Colin George Stott

Insider Network Chart

Colin George Stott Owned Company Details

What does Cardiol Therapeutics Inc do?

Who are the key executives at Cardiol Therapeutics Inc?

Colin George Stott is the Director of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , Director & Senior Officer David Elsley , and Director & Senior Officer Christopher James Waddick .

Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cardiol Therapeutics Inc Insider Transactions

No Available Data

Colin George Stott Mailing Address

Above is the net worth, insider trading, and ownership report for Colin George Stott. Currently GuruFocus does not have mailing address information for Colin George Stott.

Discussions on Colin George Stott

No discussions yet.